Work

AML-062: Long-Term Follow-Up of a Phase 1/2 Study of Venetoclax (VEN) Plus Low-Dose Cytarabine (LDAC) in Previously Untreated Older Adults with Acute Myeloid Leukemia (AML)

Year: 2020

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(20)30710-2

Authors: Andrew H. Wei, Stephen Strickland, Jing-Zhou Hou, Walter Fiedler, Tara L. Lin, Roland B. Walter, Wan-Jen Hong, Brenda Chyla, Qi Jiang, Relja Popovic, John Hayslip, Gail J. Roboz

Institutions: The Alfred Hospital, Monash University, Vanderbilt University, Vanderbilt-Ingram Cancer Center, UPMC Hillman Cancer Center, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg, University of Kansas Medical Center, Fred Hutch Cancer Center, Genentech, AbbVie (United States), Weill Cornell Medicine

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3111580720

Cites:

Cited by: 2

Related to: 10